SOLACI es la organización de referencia del intervencionismo cardiovascular latinoamericano.

Últimas Noticias

EARLY TAVR: Impact of Age on Outcomes of Early TAVR in Asymptomatic Patients

Dr. Juan Manuel Pérez - 16 June, 2026 0

Asymptomatic severe aortic stenosis represents an increasingly common clinical challenge. Although current guidelines recommend intervention once symptoms develop or left ventricular dysfunction occurs, concerns...

Plaque Ruptures in Non-Culprit Arteries: Follow-Up With Intravascular Imaging

Dr. Omar Tupayachi - 12 June, 2026 0

Plaque rupture remains one of the most important pathophysiological mechanisms in acute coronary syndromes. However, not all ruptures manifest clinically as ischemia, myocardial infarction,...

Drug-Eluting Stents in Peripheral Arterial Disease: When Should They Be Used?

Dr. Juan Manuel Pérez - 10 June, 2026 0

Peripheral drug-eluting stents have transformed the treatment of peripheral arterial disease by reducing restenosis rates and the need for repeat interventions. However, the emergence...

Accesos

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Términos de uso -Políticas de privacidad

Tag: renal denervation

Impact of Baseline Systolic Blood Pressure on Blood Pressure Changes Following...

Evolution of Renal Denervation at 24 Months

Renal Denervation and SPYRAL HTN-ON MED Two-Year Outcomes

Renal Denervation, 24-Month Evolution

Selecting Renal Denervation Responsive Patients: Meta-Analysis of Observational Data

Renal Denervation is Safe and Reduces Blood Pressure and Medication

SYMPLICITY HTN-3 Trial. Evolution at 3 Years

TCT 2022 | RADIANCE II Pivotal Trial

EuroPCR 2022 | Renal denervation increases long-term time in target blood...

ACC 2022 | SPYRAL HTN-ON: Is It Time to Start Using...

Últimas Noticias

EARLY TAVR: Impact of Age on Outcomes of Early TAVR in Asymptomatic Patients

Plaque Ruptures in Non-Culprit Arteries: Follow-Up With Intravascular Imaging

Drug-Eluting Stents in Peripheral Arterial Disease: When Should They Be Used?

Noticias Institucionales

V International Course on Cardiovascular Interventionism – SOLACI Scientific Endorsement

Guatemala Sessions 2026 – Young Interventional Cardiologists Contest – Submit Your Case

Watch Again: Clinical Implications of Structural Heart Interventions — TAVI and MitraClip in Daily Practice

Accesos